Skip to main content
Article thumbnail
Location of Repository

Jacobsen syndrome

By Teresa Mattina, Concetta Simona Perrotta and Paul Grossfeld

Abstract

Jacobsen syndrome is a MCA/MR contiguous gene syndrome caused by partial deletion of the long arm of chromosome 11. To date, over 200 cases have been reported. The prevalence has been estimated at 1/100,000 births, with a female/male ratio 2:1. The most common clinical features include pre- and postnatal physical growth retardation, psychomotor retardation, and characteristic facial dysmorphism (skull deformities, hypertelorism, ptosis, coloboma, downslanting palpebral fissures, epicanthal folds, broad nasal bridge, short nose, v-shaped mouth, small ears, low set posteriorly rotated ears). Abnormal platelet function, thrombocytopenia or pancytopenia are usually present at birth. Patients commonly have malformations of the heart, kidney, gastrointestinal tract, genitalia, central nervous system and skeleton. Ocular, hearing, immunological and hormonal problems may be also present. The deletion size ranges from ~7 to 20 Mb, with the proximal breakpoint within or telomeric to subband 11q23.3 and the deletion extending usually to the telomere. The deletion is de novo in 85% of reported cases, and in 15% of cases it results from an unbalanced segregation of a familial balanced translocation or from other chromosome rearrangements. In a minority of cases the breakpoint is at the FRA11B fragile site. Diagnosis is based on clinical findings (intellectual deficit, facial dysmorphic features and thrombocytopenia) and confirmed by cytogenetics analysis. Differential diagnoses include Turner and Noonan syndromes, and acquired thrombocytopenia due to sepsis. Prenatal diagnosis of 11q deletion is possible by amniocentesis or chorionic villus sampling and cytogenetic analysis. Management is multi-disciplinary and requires evaluation by general pediatrician, pediatric cardiologist, neurologist, ophthalmologist. Auditory tests, blood tests, endocrine and immunological assessment and follow-up should be offered to all patients. Cardiac malformations can be very severe and require heart surgery in the neonatal period. Newborns with Jacobsen syndrome may have difficulties in feeding and tube feeding may be necessary. Special attention should be devoted due to hematological problems. About 20% of children die during the first two years of life, most commonly related to complications from congenital heart disease, and less commonly from bleeding. For patients who survive the neonatal period and infancy, the life expectancy remains unknown

Topics: Review
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2670819
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2000). A: Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity
    2. (1999). AJ: 11q- syndrome: three cases and a review of the literature. Genet Couns
    3. (1973). An (11;21) translocation in four generations with chromosome 11 abnormalities in the offspring. A clinical, cytogenetical, and gene marker study. Hum Hered
    4. (2007). An 11q terminal deletion and tetralogy of Fallot.
    5. and cancer: a review. J Pathol 1999, 187(1):28-38. 2 7 . P a l k a G , V e r r o t t i A , P e c a S , M o s c a L , L o m b a r d o G , V e r r o t t i M , Morgese G: Ring chromosome 11. A case report and review of the literature. Ann Genet
    6. (2006). Anesthetic implications of Jacobsen syndrome. Pediatr Anesthesia
    7. (1999). BE: A common breakpoint on 11q23 in carriers of the constitutional t(11, 22) translocation.
    8. (2006). Bohlander SK: Association of Jacobsen Syndrome and bipolar affective disorder in a patient with a de novo 11q terminal deletion.
    9. (2004). C: The 11q terminal deletion disorder: a prospective study of 110 cases.
    10. (1996). Cavallari V: Dysmegakaryopoietic thrombocytopenia in patients with distal chromosome 11q deletion. Blood
    11. (2008). Clinical and molecular-cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an approximately 5 Mb deletion del(11)(q24.3). Am J Med Genet A
    12. (2000). Cotter F: Co-localisation of CCG repeats and chromosome deletion breakpoints in Jacobsen syndrome: evidence for a common mechanism of chromosome breakage. Hum Mol Genet
    13. (1986). den: Distal 11q monosomy. The typical 11q monosomy syndrome is due to deletion of subband 11q24.1. Clin Genet
    14. (2003). EM: Paris-Trousseau syndrome: clinical, haematological, molecular data of ten new cases. Thromb Haemost
    15. (2004). Endocrine abnormalities in patients with Jacobsen (11q-) syndrome.
    16. (1989). ER: Holoprosencephaly, ear abnormalities, congenital heart defect and microphallus in a patient with 11q- mosaicism.
    17. (1993). et al.: A novel genetic thrombocytopenia (Paris-Trousseau) associated with platelet inclusions, dysmegakaryopoiesis and chromosome deletion AT 11q23. C R Acad Sci III
    18. (1995). GA: Clinical and molecular characterization of patients with distal 11q deletion.
    19. (1998). GP: Mapping of the alpha-tector in gene (TECTA) to mouse chromosome 9 and human chromosome 11: a candidate for human autosomal dominant nonsyndromic deafness. Genomics
    20. (2008). Grossfeld P: Chromosomal microarray mapping suggests a role for BSX and Neurogranin in neurocognitive and behavioural defects in the 11q terminal deletion disorder (Jacobsen syndrome). Neurogenetics
    21. (2005). H: Further delineation of the phenotype maps for partial trisomy 16q24 and Jacobsen syndrome by a subtle familial translocation t(11;16)(q24.2;q24.1). Am J Med Genet A
    22. (1985). HG: Report of a deletion 11 (qter->q23.3) and short review of the literature.
    23. (2006). I: Prenatal diagnosis of a large de novo terminal deletion of chromosome 11q. Prenat Diagn
    24. (1998). Jacobsen's syndrome, thrombopenia and humoral immunodeficiency. Arch Pediatr
    25. (2008). Kayed HF: Distal 11q monosomy syndrome: a report of two Egyptian sibs with normal parental karyotypes confirmed confirmed by molecular cytogenetics. Genet Couns
    26. (1998). KH: Jacobsen distal 11q deletion syndrome with myelodysplatic change of haemopoietic cells.
    27. (1987). Leversha MA: Chromosome deletion at 11q23 in an abnormal child from a family with inherited fragility at 11q23. Hum Gene
    28. (2006). Molecular characterization of an 11q interstitial deletion in a patient with the clinical features of Jacobsen syndrome.
    29. (1999). MR: Localization of Jacobsen syndrome breakpoints on a 40-Mb physical map of distal chromosome 11q. Genome Res
    30. (2000). Nelkin BD: Cloning and chromosomal localization of the human BARX2 homeobox protein gene. Gene
    31. (1977). Partial deletion of long arm of chromosome 11 del 11q23: Jacobsen syndrome.
    32. (2007). Platelet storage pool deficiency in Jacobsen syndrome. Platelets
    33. (2007). Prenatal diagnosis of mosaicism for 11q terminal deletion.
    34. (2008). Rajcan-Separovic E: Submicroscopic deletions of 11q24–25 in individuals without Jacobsen syndrome: re-examination of the critical region by high-resolution array-CGH. Mol Cytogenet
    35. (1996). S: Partial deletion of the long arm of chromosome 11: ten Japanese children. Clin Genet
    36. (1994). Soukup S: Deletion of (11)(q24.2) in a mother and daughter with similar phenotypes.
    37. (2002). T: Mice deficient in nervous system-specific carbohydrate epitope HNK-1 exhibit impaired synaptic plasticity and spatial learning.
    38. (2004). T: Primary immunodeficiency in combination with transverse upper limb defect and anal atresia in a 34-year-old patient with Jacobsen syndrome.
    39. (2003). Teebi AS: Clinical and genetic aspects of trigonocephaly: a study of 25 cases.
    40. (1996). Tharapel AT: Jacobsen Syndrome: Report of a patient with severe eye anomalies, growth hormone seficiency, and hypotiroidism associated with deletion 11 (q23q25) and review of 52 cases.
    41. (1998). Tharapel AT: Most Jacobsen syndrome deletion breakpoints occur distal to FRA11B.
    42. (1990). Thuline HC: Partial deletion of the long arm of chromosome 11 [del(11)(q23.3----qter)] with abnormal white matter.
    43. (1995). Tunnacliffe A: Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature
    44. (2006). UCSC The human march
    45. (2004). W: Prenatal diagnosis of the distal 11q deletion and review of the literature. Prenat Diagn
    46. (2001). White JG: Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome.
    47. (2007). Wuyts W: A de novo subtelomeric monosomy 11q (11q24.2-qter) and trisomy 20q (20q13.3-qter) in a girl with findings compatible with Jacobsen syndrome: case report and review. Clin Dysmorphol
    48. (2001). Zuffardi O: Olfactory receptor gene clusters, genomicinversion polymorphism, and common chromosome rearrangements.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.